These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study. Belada D; Štěpánková P; Sýkorová A; Žák P; Smolej L Leuk Lymphoma; 2015 Jul; 56(7):2013-8. PubMed ID: 25330440 [TBL] [Abstract][Full Text] [Related]
4. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A; J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521 [TBL] [Abstract][Full Text] [Related]
5. Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone). Wannesson L; Bargetzi M; Cairoli A; Cerutti A; Heim D; Hess U; Lerch E; Pabst T; Renner C; Samaras P; Zucca E Leuk Lymphoma; 2013 Jan; 54(1):36-40. PubMed ID: 22702653 [TBL] [Abstract][Full Text] [Related]
6. Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles. Długosz-Danecka M; Szmit S; Kocurek A; Koźlik P; Giza A; Zimowska-Curyło D; Małkowski B; Sowa-Staszczak A; Kużdżał J; Jurczak W Pol Arch Intern Med; 2019 Apr; 129(4):259-266. PubMed ID: 30945698 [TBL] [Abstract][Full Text] [Related]
7. High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan. Kedmi M; Apel A; Davidson T; Levi I; Dann EJ; Polliack A; Ben-Bassat I; Nagler A; Avigdor A Acta Haematol; 2016; 135(3):156-61. PubMed ID: 26588173 [TBL] [Abstract][Full Text] [Related]
8. Early intensification treatment approach in advanced-stage Hodgkin lymphoma. Borchmann P Hematol Oncol Clin North Am; 2014 Feb; 28(1):65-74. PubMed ID: 24287068 [TBL] [Abstract][Full Text] [Related]
9. Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305). Kusumoto S; Munakata W; Machida R; Terauchi T; Onaya H; Oguchi M; Iida S; Nosaka K; Suzuki Y; Harada Y; Miyazaki K; Maruta M; Fukuhara N; Toubai T; Kubota N; Ohmachi K; Saito T; Rai S; Mizuno I; Fukuhara S; Takeuchi M; Tateishi U; Maruyama D; Tsukasaki K; Nagai H Cancer Sci; 2024 Oct; 115(10):3384-3393. PubMed ID: 39034771 [TBL] [Abstract][Full Text] [Related]
10. BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma. Palickova M; Mocikova H; Vernerova Z; Campr V; Kozak T Leuk Lymphoma; 2013 Sep; 54(9):2081-2. PubMed ID: 23311295 [No Abstract] [Full Text] [Related]
11. Sarcoidosis following escalated BEACOPP chemotherapy for stage IV Hodgkin lymphoma. Cho KK; Lyes SM; Shetty A Intern Med J; 2019 Apr; 49(4):547-548. PubMed ID: 30957369 [No Abstract] [Full Text] [Related]
13. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Engert A; Haverkamp H; Kobe C; Markova J; Renner C; Ho A; Zijlstra J; Král Z; Fuchs M; Hallek M; Kanz L; Döhner H; Dörken B; Engel N; Topp M; Klutmann S; Amthauer H; Bockisch A; Kluge R; Kratochwil C; Schober O; Greil R; Andreesen R; Kneba M; Pfreundschuh M; Stein H; Eich HT; Müller RP; Dietlein M; Borchmann P; Diehl V; ; ; Lancet; 2012 May; 379(9828):1791-9. PubMed ID: 22480758 [TBL] [Abstract][Full Text] [Related]
14. Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP. Franklin J; Diehl V Ann Oncol; 2002; 13 Suppl 1():98-101. PubMed ID: 12078913 [TBL] [Abstract][Full Text] [Related]
15. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group. Borchmann P; Haverkamp H; Diehl V; Cerny T; Markova J; Ho AD; Eich HT; Mueller-Hermelink HK; Kanz L; Greil R; Rank A; Paulus U; Smardova L; Huber C; Dörken B; Nerl C; Krause SW; Mueller RP; Fuchs M; Engert A J Clin Oncol; 2011 Nov; 29(32):4234-42. PubMed ID: 21990399 [TBL] [Abstract][Full Text] [Related]
16. PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study. Eichenauer DA; Kreissl S; Bühnen I; Baues C; Kobe C; van Heek L; Goergen H; Fuchs M; Hartmann S; von Tresckow B; Engert A; Borchmann P Ann Oncol; 2021 Jun; 32(6):807-810. PubMed ID: 33667668 [No Abstract] [Full Text] [Related]
17. [Escalated BEACOPP as an alternative in high risk Hodgkin lymphoma]. Jurczak W; Krochmalczyk D; Giza A; Sobociński M; Skotnicki AB Przegl Lek; 2012; 69(5):171-5. PubMed ID: 23050411 [TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma. Marzolini M; Wong WL; Ardeshna K; Padhani A; D'Sa S Br J Haematol; 2012 Mar; 156(5):557. PubMed ID: 22150023 [No Abstract] [Full Text] [Related]
19. Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study. Clin Adv Hematol Oncol; 2016 Feb; 14(2 Suppl 1):9-10. PubMed ID: 27007004 [No Abstract] [Full Text] [Related]